ID: ALA3941182

Max Phase: Preclinical

Molecular Formula: C18H17F3N2OS

Molecular Weight: 366.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cccc2c1N(C(=O)CSc1ncccc1C(F)(F)F)CCC2

Standard InChI:  InChI=1S/C18H17F3N2OS/c1-12-5-2-6-13-7-4-10-23(16(12)13)15(24)11-25-17-14(18(19,20)21)8-3-9-22-17/h2-3,5-6,8-9H,4,7,10-11H2,1H3

Standard InChI Key:  GTQOVVAPAPTVRE-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily V member 3 542 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 366.41Molecular Weight (Monoisotopic): 366.1014AlogP: 4.48#Rotatable Bonds: 3
Polar Surface Area: 33.20Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.58CX LogP: 4.32CX LogD: 4.32
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.75Np Likeness Score: -1.77

References

1.  (2015)  Compounds of modulating TRPV3 function, 

Source

Source(1):